Added to YB: 2018-12-28
Pitch date: 2018-12-28
OMED [bullish]
OncoMed Pharmaceuticals, Inc.
+21.92%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics that address the fundamental biology driving cancer’s growth, resistance, recurrence, and metastasis.
Market Cap
$34.4M
Pitch Price
$0.73
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-4.22
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
ONCOMED PHARMACEUTICALS OMED
A summary for this pitch has not been created yet.
Read full article (0 min)